Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients

Transfusion medicine is traditionally a strong/fundamental part of clinical practice, saving hundreds millions lives. However, blood-borne or transmitted infections are well-known and feared possibility, risk we relentlessly mitigate. Pathogens continuously rather quickly changing, so during the last decade, many, sometimes exotic, new pathogens diseases were recorded analyzed, some them proved to be with transfusions. Blood blood component transfusions carried out after cautious preparative screening inactivation maneuvers, but in instances, newly recognized agents might escape from standard procedures. Here, try focus on these proven potentially pathogenic transfusion-transmitted agents, especially immunocompromised patients bone marrow transplantation settings. These challenges for procedures, there need more recent, occasionally advanced, methods recognize eliminate threat pathogen can pose. Pathogen transmission probably even critical hemophiliacs transplant recipients, who receive plasma-derived factor preparations regularly large quantities, severely immunosuppressed conditions. Moreover, it may not emphasized enough that product administrations essential medical care. Therefore, needs continued alertness efforts attain optimal benefits minimized hazards.